Company intelligence / Profile preview

The cGP Lab

Auckland, Auckland, New Zealandcgp-health.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company has commercialized two science-backed supplements containing standardized doses of natural cyclic Glycine-Proline (cGP), with clinical research supporting brain and cardiovascular benefits. Early-stage research suggests potential benefit in neurodegenerative diseases such as Parkinson’s and age-related cognitive impairment. A new product targeting diabetic peripheral neuropathy is under development.

Therapeutic areas: CardiovascularEndocrinologyNeurology
Modalities: Natural dipeptide (cyclic Glycine-Proline/cGP)Functional foods and dietary supplements
Industry: Food & Nutrition

Drug pipeline

2 assets

cGP-PRo

Commercial

Indications: Diabetic peripheral neuropathy, Diabetic nephropathy

1 more asset in the full pipeline.

Request access →

Partnerships

None specifically named; collaborates with manufacturing/research partners to develop production processes.

Beyond the preview

Go deeper on The cGP Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The cGP Lab.

Explore the full profile